Venrock Adviser, LLC Diversified Active

Location: New York, NY

CIK: 0001615982 · Show all filings

Period: Q3 2020 (← Previous) (Next →)

Filing Date: Nov 16, 2020

Total Value: $511M (100.0% shares, 0.0% debt)

Holdings (22)

— TRILLIUM THERAPEUTICS INC 20.0%

Value $102M Shares 7,204,577 Est. Cost $4.63 Unrealized —

— CONSTELLATION PHARMACEUTICAL 15.9%

Value $81.38M Shares 4,016,873 Est. Cost $31.43 Unrealized —

ALT ALTIMMUNE INC 11.6%

Value $59.4M Shares 4,500,000 Est. Cost $5.49 Unrealized +263.9%

— ATHIRA PHARMA INC 5.5%

Value $28.09M Shares 1,521,623 Est. Cost $18.46 Unrealized —

— SURFACE ONCOLOGY INC 5.2%

Value $26.76M Shares 3,877,895 Est. Cost $6.56 Unrealized —

KROS KEROS THERAPEUTICS INC 5.1%

Value $25.93M Shares 672,306 Est. Cost $30.81 Unrealized +28.7%

RLMD RELMADA THERAPEUTICS INC 4.9%

Value $25.15M Shares 668,440 Est. Cost $40.32 Unrealized -4.1%

— HUMANIGEN INC 4.9%

Value $24.82M Shares 2,332,516 Est. Cost $10.64 Unrealized —

CRDF CARDIFF ONCOLOGY INC 3.5%

Value $18.05M Shares 1,271,985 Est. Cost $6.60 Unrealized 0.0%

— IMV INC 3.5%

Value $17.76M Shares 4,000,000 Est. Cost $4.44 Unrealized —

KURA KURA ONCOLOGY INC 3.4%

Value $17.62M Shares 575,000 Est. Cost $14.42 Unrealized +53.1%

— MARINUS PHARMACEUTICALS INC 3.0%

Value $15.33M Shares 1,192,883 Est. Cost $2.03 Unrealized —

CLDX CELLDEX THERAPEUTICS INC 2.3%

Value $11.86M Shares 800,000 Est. Cost $11.71 Unrealized 0.0%

— METACRINE INC 2.3%

Value $11.68M Shares 1,143,673 Est. Cost $10.21 Unrealized —

ALXO ALX ONCOLOGY HOLDINGS INC 2.2%

Value $11.32M Shares 300,000 Est. Cost $39.31 Unrealized 0.0%

— UNUM THERAPEUTICS INC 2.0%

Value $10.19M Shares 4,355,273 Est. Cost $2.34 Unrealized —

SNDX SYNDAX PHARMACEUTICALS INC 1.8%

Value $9.235M Shares 625,710 Est. Cost $15.23 Unrealized +0.1%

— FS DEVELOPMENT CORP-A 1.1%

Value $5.599M Shares 500,000 Est. Cost $11.20 Unrealized —

— BCTG ACQUISITION CORP 1.0%

Value $5.18M Shares 500,000 Est. Cost $10.36 Unrealized —

TSHA TAYSHA GENE THERAPIES INC 0.5%

Value $2.598M Shares 107,982 Est. Cost $23.52 Unrealized 0.0%

GRTX GALERA THERAPEUTICS INC 0.1%

Value $467K Shares 51,653 Est. Cost $7.92 Unrealized 0.0%

MDNAF MEDICENNA THERAPEUTICS CORP 0.1%

Value $383K Shares 92,453 Est. Cost $4.05 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	TRILLIUM THERAPEUTICS INC	7,204,577	$102M	20.0%	$4.63	—	COM	89620X506
—	CONSTELLATION PHARMACEUTICAL	4,016,873	$81.38M	15.9%	$31.43	—	COM	210373106
ALT	ALTIMMUNE INC	4,500,000	$59.4M	11.6%	$5.49	+263.9%	COM	02155H200
—	ATHIRA PHARMA INC	1,521,623	$28.09M	5.5%	$18.46	—	COM	04746L104
—	SURFACE ONCOLOGY INC	3,877,895	$26.76M	5.2%	$6.56	—	COM	86877M209
KROS	KEROS THERAPEUTICS INC	672,306	$25.93M	5.1%	$30.81	+28.7%	COM	492327101
RLMD	RELMADA THERAPEUTICS INC	668,440	$25.15M	4.9%	$40.32	-4.1%	COM	75955J402
—	HUMANIGEN INC	2,332,516	$24.82M	4.9%	$10.64	—	COM	444863104
CRDF	CARDIFF ONCOLOGY INC	1,271,985	$18.05M	3.5%	$6.60	0.0%	COM	14147L108
—	IMV INC	4,000,000	$17.76M	3.5%	$4.44	—	COM	44974L103
KURA	KURA ONCOLOGY INC	575,000	$17.62M	3.4%	$14.42	+53.1%	COM	50127T109
—	MARINUS PHARMACEUTICALS INC	1,192,883	$15.33M	3.0%	$2.03	—	COM	56854Q101
CLDX	CELLDEX THERAPEUTICS INC	800,000	$11.86M	2.3%	$11.71	0.0%	COM	15117B202
—	METACRINE INC	1,143,673	$11.68M	2.3%	$10.21	—	COM	59101E103
ALXO	ALX ONCOLOGY HOLDINGS INC	300,000	$11.32M	2.2%	$39.31	0.0%	COM	00166B105
—	UNUM THERAPEUTICS INC	4,355,273	$10.19M	2.0%	$2.34	—	COM	903214104
SNDX	SYNDAX PHARMACEUTICALS INC	625,710	$9.235M	1.8%	$15.23	+0.1%	COM	87164F105
—	FS DEVELOPMENT CORP-A	500,000	$5.599M	1.1%	$11.20	—	COM CL A	303020101
—	BCTG ACQUISITION CORP	500,000	$5.18M	1.0%	$10.36	—	COM	05492W103
TSHA	TAYSHA GENE THERAPIES INC	107,982	$2.598M	0.5%	$23.52	0.0%	COM SHS	877619106
GRTX	GALERA THERAPEUTICS INC	51,653	$467K	0.1%	$7.92	0.0%	COM	36338D108
MDNAF	MEDICENNA THERAPEUTICS CORP	92,453	$383K	0.1%	$4.05	0.0%	COM	58490H107